➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Express Scripts
McKinsey
Merck
Johnson and Johnson

Last Updated: August 1, 2021

DrugPatentWatch Database Preview

Details for Patent: 8,927,595


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,927,595 protect, and when does it expire?

Patent 8,927,595 protects SKLICE and is included in one NDA.

This patent has twenty-six patent family members in thirteen countries.

Summary for Patent: 8,927,595
Title:Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice
Abstract: An avermectin-based topical formulation is disclosed which is useful for prevention and treatment of head lice (Pediculus humanus capitis). This topical formulation may be formulated as a shampoo-condition which comprises an effective amount of avermectin, solubilizers, suspending agents, preservatives, non-ionic surfactants, humectants, a silicone compound, and water. Also disclosed are methods of using the topical formulations disclosed within this specification to treat either a susceptible or treatment-resistant strain of lice, as well as uses in the manufacture of a medicament for treating or preventing a lice infestation from a susceptible or treatment-resistant strain in a human patient.
Inventor(s): Spring; Nicholas (Horsham, PA), Gwozdz; Garry T. (Bethlehem, PA)
Assignee: Sanofi-Topaz, Inc. (Wilmington, DE)
Application Number:13/116,547
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,927,595
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;

Recent additions to Drugs Protected by US Patent 8,927,595

These patents are from the daily update and have not yet been integrated into the regular database
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist Req. Patent Expiration Usecode Patented / Exclusive Use
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Type >RLD >Patent No. >Product >Substance >Delist Req. >Patent Expiration >Usecode >Patented / Exclusive Use

Drugs Protected by US Patent 8,927,595

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Arbor Pharms Llc SKLICE ivermectin LOTION;TOPICAL 202736-001 Feb 7, 2012 OTC Yes Yes ⤷  Try it Free ⤷  Try it Free Y FOR HEAD LICE INFESTATIONS ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,927,595

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2009308922 ⤷  Try it Free
Australia 2016201858 ⤷  Try it Free
Canada 2666365 ⤷  Try it Free
Canada 2686336 ⤷  Try it Free
Canada 2741886 ⤷  Try it Free
China 102231948 ⤷  Try it Free
European Patent Office 2091325 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Baxter
Dow
Merck
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.